Search

Arthur S. Leonard

Examiner (ID: 12301, Phone: (571)270-3073 , Office: P/1633 )

Most Active Art Unit
1633
Art Unit(s)
1631, 1633
Total Applications
655
Issued Applications
267
Pending Applications
112
Abandoned Applications
289

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 11350224 [patent_doc_number] => 20160368964 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-22 [patent_title] => 'TRIFUNCTIONAL T CELL-ANTIGEN COUPLER AND METHODS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 15/117173 [patent_app_country] => US [patent_app_date] => 2015-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 12926 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15117173 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/117173
Trifunctional T cell-antigen coupler and methods and uses thereof Feb 5, 2015 Issued
Array ( [id] => 11901069 [patent_doc_number] => 09770489 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-09-26 [patent_title] => 'Methods and products for nucleic acid production and delivery' [patent_app_type] => utility [patent_app_number] => 14/761461 [patent_app_country] => US [patent_app_date] => 2015-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 18 [patent_no_of_words] => 37184 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14761461 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/761461
Methods and products for nucleic acid production and delivery Jan 29, 2015 Issued
Array ( [id] => 10331143 [patent_doc_number] => 20150216148 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-06 [patent_title] => 'ORANGE TRANSGENIC FLUORESCENT ORNAMENTAL FISH' [patent_app_type] => utility [patent_app_number] => 14/609665 [patent_app_country] => US [patent_app_date] => 2015-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2850 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14609665 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/609665
Orange transgenic fluorescent ornamental fish Jan 29, 2015 Issued
Array ( [id] => 11772051 [patent_doc_number] => 09380768 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-07-05 [patent_title] => 'Red transgenic fluorescent ornamental fish' [patent_app_type] => utility [patent_app_number] => 14/609717 [patent_app_country] => US [patent_app_date] => 2015-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2850 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14609717 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/609717
Red transgenic fluorescent ornamental fish Jan 29, 2015 Issued
Array ( [id] => 10814025 [patent_doc_number] => 20160160186 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-09 [patent_title] => 'THERAPEUTIC PHAGES AND METHODS FOR DELIVERY OF NUCLEIC ACIDS FOR THERAPEUTIC USES' [patent_app_type] => utility [patent_app_number] => 14/605320 [patent_app_country] => US [patent_app_date] => 2015-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9157 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14605320 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/605320
Therapeutic phages and methods for delivery of nucleic acids for therapeutic uses Jan 25, 2015 Issued
Array ( [id] => 11130576 [patent_doc_number] => 20160327551 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-11-10 [patent_title] => 'SERS NANOPARTICLES AND METHODS FOR USING THE SAME' [patent_app_type] => utility [patent_app_number] => 15/108555 [patent_app_country] => US [patent_app_date] => 2015-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 15370 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15108555 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/108555
SERS NANOPARTICLES AND METHODS FOR USING THE SAME Jan 22, 2015 Abandoned
Array ( [id] => 11270773 [patent_doc_number] => 20160333321 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-11-17 [patent_title] => 'ASSAY AND MEDICAMENT' [patent_app_type] => utility [patent_app_number] => 15/111615 [patent_app_country] => US [patent_app_date] => 2015-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 16557 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15111615 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/111615
ASSAY AND MEDICAMENT Jan 15, 2015 Abandoned
Array ( [id] => 10234562 [patent_doc_number] => 20150119556 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-30 [patent_title] => 'Histidine Engineered Light Chain Antibodies and Genetically Modified Non-Human Animals for Generating the Same' [patent_app_type] => utility [patent_app_number] => 14/589249 [patent_app_country] => US [patent_app_date] => 2015-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 71 [patent_figures_cnt] => 71 [patent_no_of_words] => 54996 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14589249 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/589249
Histidine Engineered Light Chain Antibodies and Genetically Modified Non-Human Animals for Generating the Same Jan 4, 2015 Abandoned
Array ( [id] => 10333543 [patent_doc_number] => 20150218547 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-06 [patent_title] => 'Cell Line, System and Method for Optical Control of Secondary Messengers' [patent_app_type] => utility [patent_app_number] => 14/589756 [patent_app_country] => US [patent_app_date] => 2015-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7184 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14589756 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/589756
Cell line, system and method for optical control of secondary messengers Jan 4, 2015 Issued
Array ( [id] => 10813712 [patent_doc_number] => 20160159873 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-09 [patent_title] => 'RESEARCH BIO-NANOPARTICLE ELEMENTS AND PLATFORMS' [patent_app_type] => utility [patent_app_number] => 14/562051 [patent_app_country] => US [patent_app_date] => 2014-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 33653 [patent_no_of_claims] => 213 [patent_no_of_ind_claims] => 163 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14562051 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/562051
RESEARCH BIO-NANOPARTICLE ELEMENTS AND PLATFORMS Dec 4, 2014 Abandoned
Array ( [id] => 10268329 [patent_doc_number] => 20150153326 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-04 [patent_title] => 'QUANTITATIVE ANALYSIS OF CONTACT-DEPENDENT CELL-TO-CELL TRANSFER AND DISEASE TRANSMISSION' [patent_app_type] => utility [patent_app_number] => 14/553281 [patent_app_country] => US [patent_app_date] => 2014-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 16460 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14553281 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/553281
QUANTITATIVE ANALYSIS OF CONTACT-DEPENDENT CELL-TO-CELL TRANSFER AND DISEASE TRANSMISSION Nov 24, 2014 Abandoned
Array ( [id] => 11099593 [patent_doc_number] => 20160296562 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-10-13 [patent_title] => 'CELL' [patent_app_type] => utility [patent_app_number] => 15/037391 [patent_app_country] => US [patent_app_date] => 2014-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 21639 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15037391 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/037391
CELL Nov 20, 2014 Abandoned
Array ( [id] => 11100890 [patent_doc_number] => 20160297860 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-10-13 [patent_title] => 'IDENTIFICATION OF A NOVEL B CELL CYTOKINE' [patent_app_type] => utility [patent_app_number] => 15/036207 [patent_app_country] => US [patent_app_date] => 2014-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 18850 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15036207 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/036207
IDENTIFICATION OF A NOVEL B CELL CYTOKINE Nov 19, 2014 Abandoned
Array ( [id] => 10311582 [patent_doc_number] => 20150196584 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-16 [patent_title] => 'OXYGEN-CONTROLLABLE AND HYPOXIA-INDUCIBLE HYDROGELS' [patent_app_type] => utility [patent_app_number] => 14/536392 [patent_app_country] => US [patent_app_date] => 2014-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 19611 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14536392 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/536392
OXYGEN-CONTROLLABLE AND HYPOXIA-INDUCIBLE HYDROGELS Nov 6, 2014 Abandoned
Array ( [id] => 10219870 [patent_doc_number] => 20150104863 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-16 [patent_title] => 'VECTORS AND SEQUENCES FOR THE TREATMENT OF DISEASES' [patent_app_type] => utility [patent_app_number] => 14/531200 [patent_app_country] => US [patent_app_date] => 2014-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 10976 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14531200 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/531200
Vectors and sequences for the treatment of diseases Nov 2, 2014 Issued
Array ( [id] => 11046301 [patent_doc_number] => 20160243260 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-25 [patent_title] => 'Treatment of neurological diseases using adeno-associated virus (AAV) comprising AAV-5 capsid proteins' [patent_app_type] => utility [patent_app_number] => 15/031782 [patent_app_country] => US [patent_app_date] => 2014-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 15750 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15031782 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/031782
Treatment of neurological diseases using adeno-associated virus (AAV) comprising AAV-5 capsid proteins Oct 23, 2014 Abandoned
Array ( [id] => 11350557 [patent_doc_number] => 20160369298 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-22 [patent_title] => 'SYNTHETIC COMBINATORIAL AAV CAPSID LIBRARY FOR TARGETED GENE THERAPY' [patent_app_type] => utility [patent_app_number] => 15/024431 [patent_app_country] => US [patent_app_date] => 2014-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 21436 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15024431 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/024431
SYNTHETIC COMBINATORIAL AAV CAPSID LIBRARY FOR TARGETED GENE THERAPY Sep 25, 2014 Abandoned
Array ( [id] => 10209529 [patent_doc_number] => 20150094518 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-02 [patent_title] => 'MODULAR POLYMER PLATFORM FOR THE TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 14/498005 [patent_app_country] => US [patent_app_date] => 2014-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 22245 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14498005 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/498005
MODULAR POLYMER PLATFORM FOR THE TREATMENT OF CANCER Sep 25, 2014 Abandoned
Array ( [id] => 11323877 [patent_doc_number] => 20160354489 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-08 [patent_title] => 'GENE THERAPY COMPOSITIONS FOR USE IN THE PREVENTION AND/OR TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE' [patent_app_type] => utility [patent_app_number] => 15/024821 [patent_app_country] => US [patent_app_date] => 2014-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 16476 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15024821 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/024821
GENE THERAPY COMPOSITIONS FOR USE IN THE PREVENTION AND/OR TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE Sep 24, 2014 Abandoned
Array ( [id] => 16756818 [patent_doc_number] => 10975358 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-04-13 [patent_title] => Method for improving efficiency of inducing pluripotent stem cell [patent_app_type] => utility [patent_app_number] => 15/023484 [patent_app_country] => US [patent_app_date] => 2014-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 25872 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 238 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15023484 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/023484
Method for improving efficiency of inducing pluripotent stem cell Sep 23, 2014 Issued
Menu